Jane Street’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,031
Closed -$40.6K 11761
2025
Q4
$40.6K Buy
8,031
+5,956
+287% +$64.8K ﹤0.01% 10564
2025
Q3
$21.4K Sell
2,075
-3,467
-63% -$32.2K ﹤0.01% 10523
2025
Q2
$46.6K Buy
5,542
+4,204
+314% +$39.3K ﹤0.01% 9195
2025
Q1
$12.4K Buy
1,338
+473
+55% +$9.04K ﹤0.01% 9181
2024
Q4
$19.5K Sell
865
-606
-41% -$19.1K ﹤0.01% 9133
2024
Q3
$55.2K Buy
+1,471
New +$56.5K ﹤0.01% 9160
2024
Q1
Sell
-1,580
Closed -$63.1K 9288
2023
Q4
$63.1K Buy
1,580
+719
+84% +$25.3K ﹤0.01% 8722
2023
Q3
$27.4K Buy
+861
New +$32.5K ﹤0.01% 8262
2023
Q2
Sell
-495
Closed -$22K 8770
2023
Q1
$22K Sell
495
-781
-61% -$62.6K ﹤0.01% 8624
2022
Q4
$96.5K Buy
1,276
+348
+38% +$32.6K ﹤0.01% 8115
2022
Q3
$89K Buy
+928
New +$130K ﹤0.01% 8708
2022
Q2
Sell
-2,592
Closed -$480K 9765
2022
Q1
$480K Buy
+2,592
New +$537K ﹤0.01% 7567
2021
Q3
Sell
-2,007
Closed -$586K 9997
2021
Q2
$497K Buy
2,007
+1,468
+272% +$377K ﹤0.01% 7258
2021
Q1
$154K Buy
539
+154
+40% +$61.5K ﹤0.01% 8446
2020
Q4
$107K Sell
385
-1,559
-80% -$578K ﹤0.01% 7185
2020
Q3
$793K Buy
+1,944
New +$999K ﹤0.01% 4466
2020
Q2
Sell
-2,263
Closed -$1.03M 7098
2020
Q1
$517K Buy
+2,263
New +$392K ﹤0.01% 3596

Other funds holding CODX

Jane Street's CODX Position: Q1 2026 in Review

Jane Street sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 8,031 shares — an estimated $40.6K sold.

Jane Street first reported a position in CODX in Q1 2020 and held it in 17 quarters. The position peaked at $793K in Q3 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Jane Street reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 8,031 Co-Diagnostics shares in Q1 2026, an estimated $40.6K.
  • Jane Street first reported a position in Co-Diagnostics in Q1 2020 and held it in 17 quarters.
  • Jane Street's Co-Diagnostics position peaked at $793K in Q3 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.